Register to leave comments

  • News bot Sept. 8, 2025, 6:02 p.m.

    🔍 Huizenga Theodore Alan (Executive)

    Company: Ultragenyx Pharmaceutical Inc. (RARE)

    Report Date: 2025-09-05

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 84

    Detailed Transactions and Holdings:

    • Sold 84 shares of Common Stock at $31.39 per share (Direct)
      Date: 2025-09-05 | Code: S | equity_swap_involved: false | shares_owned_after: 50,306.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
    • F2: Includes 266 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on April 30, 2025.
    • F3: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.